卡斯尔生物科技

US · CSTL #3242 按市值排名上市于 2019

31.96 -1.84 -5.44%

实时 - 追踪5344个代码 - 心跳于572秒前 · 2026-10-16 20:02

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了1家。
机构持股总比例下降了1.3个百分点。

机构持股

机构持股比例: 90.73% -1.26pp
机构数量: 216 -1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund61.16%

Hedge Fund22.15%

Public Company4.32%

Individual/Insider2.02%

Private Company1.07%

Government Pension Fund1.03%

Insurance Company0.74%

Sovereign Wealth Fund0.21%

Other7.24%

主要股东截至 2026-06-30

BlackRock 10.78% · 3.29M 股

RTW Investments, LP 9.09% · 2.78M 股

Principal Global Investors, LLC 5.65% · 1.73M 股

Vanguard Capital Management, LLC 4.66% · 1.42M 股

Acadian Asset Management LLC 3.01% · 918.67K 股

Allianz Asset Management AG 2.88% · 879.26K 股

Vanguard Portfolio Management, LLC 2.75% · 840.79K 股

Summit Partners Public Asset Management, LLC 2.70% · 824.87K 股

State Street Global Advisors 2.69% · 822.08K 股

Geode Capital Management, LLC 2.61% · 795.91K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 13次买入 · 37次卖出

姓名	职务	持股比例
Derek Maetzold	Chief Executive Officer	0.63%
Kristen Oelschlager	Chief Operating Officer	0.28%
Tobin Juvenal	Chief Commercial Officer	0.17%
Ellen Goldberg	Independent Director	0.13%
Tiffany Olson	Independent Director	0.13%
Kimberlee Caple	Independent Director	0.12%
Daniel Bradbury	Independent Chairperson	0.12%
Miles Harrison	Independent Director	0.12%
Frank Stokes	Chief Financial Officer	0.12%
Rodney Cotton	Independent Director	0.11%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-10-04	Derek Maetzold	Chief Executive Officer	Intent to Sell (Form 144)	-28,992	$36.65
2026-09-30	Kristen Oelschlager	Chief Operating Officer	Derivative Exercise and Sale	-4,153	$3.38–36.38
2026-09-29	Tobin Juvenal	Chief Commercial Officer	Automatic Disposition	-6,577	$34.20–35.50
2026-09-20	Derek Maetzold	Chief Executive Officer	Automatic Disposition	-5,916	$35.33
2026-09-20	Derek Maetzold	Chief Executive Officer	Derivative Exercise and Sale	-8,580	$2.39–35.33
2026-09-14	Tobin Juvenal	Chief Commercial Officer	Automatic Disposition	-6,600	$32.32–35.14
2026-09-10	Derek Maetzold	Chief Executive Officer	Automatic Disposition	-5,934	$32.00–32.78
2026-09-10	Derek Maetzold	Chief Executive Officer	Derivative Exercise and Sale	-8,584	$2.39–32.00
2026-08-31	Kristen Oelschlager	Chief Operating Officer	Derivative Exercise and Sale	-4,152	$3.38–34.02
2026-08-30	Tobin Juvenal	Chief Commercial Officer	Automatic Disposition	-1,730	$32.81
2026-08-27	Derek Maetzold	Chief Executive Officer	Automatic Disposition	-6,132	$33.14–33.88
2026-08-27	Derek Maetzold	Chief Executive Officer	Derivative Exercise and Sale	-12,428	$2.39–33.14
2026-08-24	Tobin Juvenal	Chief Commercial Officer	Automatic Disposition	-9,050	$35.04
2026-08-24	Kristen Oelschlager	Chief Operating Officer	Open Market Disposition	-24,602	$33.69–34.64
2026-08-16	Tobin Juvenal	Chief Commercial Officer	Automatic Disposition	-1,730	$29.59
2026-08-13	Derek Maetzold	Chief Executive Officer	Automatic Disposition	-6,132	$30.02
2026-08-13	Derek Maetzold	Chief Executive Officer	Derivative Exercise and Sale	-1,100	$2.39–30.02
2026-08-13	Frank Stokes	Chief Financial Officer	Open Market Disposition	-24,908	$29.77
2026-08-04	Derek Maetzold	Chief Executive Officer	Automatic Disposition	-16,114	$30.68–31.34
2026-08-04	Derek Maetzold	Chief Executive Officer	Derivative Exercise and Sale	-22,902	$2.39–31.34

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:14 · 仅供参考，不构成投资建议，也未考虑您的具体情况。